GUTS Stock — Fractyl Health, Inc. Common Stock

Fractyl Health, Inc. Common Stock (GUTS)

Updated October 16, 2026.

GUTS is a Stock. Its deepest 1-year drawdown was 94.5%.

Fractyl Health is a metabolic therapeutics company developing procedural and gene therapy treatments for type 2 diabetes and obesity, including its Revita DMR System for duodenal modification and Rejuva, a pancreatic gene therapy platform. The company does not currently distribute dividends. This security is primarily of interest to those seeking exposure to early-stage biotechnology development rather than income investors.

GUTS performance

Returns are updating. GUTS's total return appears here after the next nightly update.

Its deepest 1-year drawdown was 94.5%.

GUTS key facts

Asset type

Stock

Asset class

Equity

Inception date

02/01/2024

Distribution frequency

None

Last close

$1.55 (as of 2026-10-16)

Market cap

$246,728,764

Average volume

14814160.0

Beta

2.334

Payout ratio

0.0%

EPS

$-0.91

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

GUTS risks and drawbacks

The deepest 1-year drawdown on record here is 94.5%.

Who may consider GUTS — and who may not

It is a weaker fit for investors who need monthly cash flow (GUTS does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on GUTS

• All tickers starting with G

Tagged: Healthcare.

Frequently asked questions